SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-087533
Filing Date
2020-07-29
Accepted
2020-07-29 06:06:30
Documents
5
Period of Report
2020-07-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2025424d2_8k.htm 8-K 24363
2 EXHIBIT 5.1 tm2025424d2_ex5-1.htm EX-5.1 10933
3 EXHIBIT 10.1 tm2025424d2_ex10-1.htm EX-10.1 240339
4 GRAPHIC tm2025424d2_ex5-1img001.jpg GRAPHIC 4848
5 GRAPHIC tm2025424d2_ex5-1img002.jpg GRAPHIC 1959
  Complete submission text file 0001104659-20-087533.txt   286506
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 201055621
SIC: 2834 Pharmaceutical Preparations